Warning: Last items in stock!
Afanix（Afatinib）is a generic kinase inhibitor indicated for:
1.First-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have non-resistant epidermal growth factor receptor (EGFR) mutations as detected by an FDA-approved test.
Limitation of Use: Safety and efficacy of Afatinib were not established in patients whose tumors have resistant EGFR mutations
2.Treatment of patients with metastatic, squamous NSCLC progressing after platinum-based chemotherapy
1.Recommended dose: 40 mg orally, once daily
2.Renal impairment: 30 mg orally, once daily in patients with severe renal impairment
3.Instruct patients to take Afatinib at least 1 hour before or 2 hours after a meal
Afatinib Side Effects
The most common side effects of Afatinib include:
diarrhea rash mouth sores nail inflammation dry skin acne decreased appetite nausea vomiting itching
For more Prescribing information，please check the → “FDA Prescribing Information”.
|Warnings||Don't take the drug without consulting a qualified doctor or physician|
|Suggested use||Follow the doctor's advice|
|Delivery & Returns||7-14 Days|